Compounds > l-pyroglutamyl-l-histidyl-3,3-dimethylprolinamide
Page last updated: 2024-09-02

l-pyroglutamyl-l-histidyl-3,3-dimethylprolinamide and doxapram

l-pyroglutamyl-l-histidyl-3,3-dimethylprolinamide has been researched along with doxapram in 1 studies

Compound Research Comparison

Studies
(l-pyroglutamyl-l-histidyl-3,3-dimethylprolinamide)		Trials
(l-pyroglutamyl-l-histidyl-3,3-dimethylprolinamide)		Recent Studies (post-2010)
(l-pyroglutamyl-l-histidyl-3,3-dimethylprolinamide)		Studies
(doxapram)		Trials
(doxapram)		Recent Studies (post-2010) (doxapram)
138725969572

Protein Interaction Comparison

ProteinTaxonomyl-pyroglutamyl-l-histidyl-3,3-dimethylprolinamide (IC50)doxapram (IC50)
Potassium channel subfamily K member 3Rattus norvegicus (Norway rat)0.41
Cytochrome P450 2D6Homo sapiens (human)0.1

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Dettmar, PW; Fortune, D; Lynn, AG; Metcalf, G; Morgan, BA1

Other Studies

1 other study(ies) available for l-pyroglutamyl-l-histidyl-3,3-dimethylprolinamide and doxapram

ArticleYear
Biological evaluation of a TRH analogue with a modified proline residue.
    Neuropharmacology, 1980, Volume: 19, Issue:12

    Topics: Amitriptyline; Amphetamine; Doxapram; Humans; Pyrrolidonecarboxylic Acid; Thyrotropin-Releasing Hormone

1980